Redcliffe Lifetech introduces Mucormycosis Multiplex RT-PCR test to diagnose mucormycosis

The company is pricing the test at Rs 7,000

In order to help government in the diagnosis of mucormycosis, Redcliffe Lifetech has introduced a non-invasive (Serum/Fluid) RT-PCR test to detect the DNA of mucorales species. As a part of the diagnostic process, Bronchoalveolar lavage (BAL) samples will be used to directly detect the infection, with sample-to-result collection in less than 24 hours, a statement from the company said.

The company is pricing the test at Rs 7,000, according to the statement.

It also said that Redcliffe Lifetech will collect various samples for conducting RT-PCR tests like Bronchoalveolar lavage (BAL) samples, biopsy samples, paraffin embedded, serum samples to detect the potential health disorder or diseases in people. The diagnosis of mucormycosis will target pan-mucormycetes, rhizopus spp., mucor spp., lichtheimis spp., cunninghamella spp., rhizomucor spp., internal control (IC).

Commenting on the announcement, Dheeraj Jain, Managing Director, Redcliffe Lifetech, said, “We endeavour to assist the Government of India and the general public in combating this deadly infection with the most advanced approach. With the help of our technology, we can assist them in a timely diagnosis of mucormycosis. This will undoubtedly aid in the diagnosis and treatment of patients.”